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Abstract The membrane anchoring of the following glycohy-
drolases of human erythrocyte plasma membranes was investi-
gated: K- and L-D-glucosidase, K- and L-D-galactosidase, L-D-
glucuronidase, N-acetyl-L-D-glucosaminidase, K-D-mannosidase,
and K-L-fucosidase. Optimized fluorimetric methods for the
assay of these enzymes were set up. Treatment of the ghost
preparation with 1.0 mol/l (optimal concentration) NaCl caused
release ranging from 4.2% of K-D-glucosidase to 70% of L-D-
galactosidase; treatment with 0.4% (optimal concentration)
Triton X-100 liberated 5.1% of L-D-galactosidase to 89% of
K-D-glucosidase; treatment with 1.75% (optimal concentration)
octylglucoside yielded solubilization from 6.3% of L-D-galacto-
sidase to 85% of K-D-glucosidase. Treatment with phosphoinosi-
tide-specific phospholipase C caused no liberation of any of the
studied glycohydrolases. These results are consistent with the
notion that the above glycohydrolases are differently anchored or
associated with the erythrocyte plasma membrane, and provide
the methodological basis for inspecting the occurrence of these
enzymes in different membrane microdomains.
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1. Introduction
The glycohydrolases are ubiquitous enzymes, being found
in lysosomes, plasma membrane, cytosol, and blood plasma
[1^5]. In each subcellular location glycohydrolases may be
present in di¡erent forms, as shown by N-acetyl-L-D-glucos-
aminidase and sialidase [6,7]. Glycohydrolases from lysosomes
have an acidic optimal pH [8], whereas those present in plas-
ma membranes and cytosol may have an optimal pH in the
neutral range [6,9]. The insertion of glycohydrolases into the
plasma membrane is assumed to occur through a transmem-
brane hydrophobic domain. However, examples are known of
other types of anchoring [10].
Several glycohydrolases, all with an acidic pH optimum
[11], were detected in the plasma membrane of human eryth-
rocytes [11,12]. Recently, two forms of sialidase were de-
scribed [6,12], one with a neutral pH optimum, the other
one with an acidic pH optimum, which is released by treat-
ment with phosphoinositide-speci¢c phospholipase C
(PIPLC), suggesting the presence of a glycanphosphoinositide
(GPI) type of attachment [10]. By treatment with di¡erent
detergents, it was also demonstrated that the acidic and neu-
tral forms of sialidase likely pertain to di¡erent membrane
domains [6]. There is growing evidence, arising mostly from
studies on polarized cells (neurons, epithelial cells), that some
proteins and lipid components of the plasma membrane are
unevenly distributed on the surface and are enriched in mem-
brane microdomains (caveolae, lipid rafts, glycosphingolipid-
enriched microdomains) that can be isolated and analyzed
[13^18]. It is conceived that some proteins present in micro-
domains are responsible for both the formation and function-
al performance (recognition and signalling events) of these
membrane structures [16]. Although the presence of microdo-
mains in human erythrocyte membranes was never studied as
such, some data are consistent with this possibility [19^21],
including the microvesiculation process occurring during hu-
man erythrocyte ageing [22]. Therefore, it seems interesting to
explore whether other erythrocyte glycohydrolases, besides
sialidase, have di¡erent modes of membrane anchoring, with
possible involvement in di¡erent membrane microdomains,
and whether these di¡erential patterns a¡ect the physiopathol-
ogy of the erythrocyte surface. Interestingly, changes in the
glycohydrolase set of human erythrocyte membranes due to
diseases of infective or genetic origin have been reported
[23,24].
We have investigated here the mode of attachment of the
following glycohydrolases to the membrane of normal human
erythrocytes: L-GlcNAc-ase, L-GlcA-ase, L-Gal-ase, K-Gal-
ase, L-Glc-ase, K-Glc-ase, K-Man-ase, K-Fuc-ase. The results
obtained are consistent with the notion that glycohydrolases
are unevenly distributed on the erythrocyte surface and con-
stitute the basis for more focussed investigations on the pos-
sible di¡erential distribution of glycohydrolases in membrane
microdomains.
2. Materials and methods
2.1. Materials
Commercial chemicals were of the highest available grade. The
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water routinely used was freshly redistilled in a glass apparatus. 4-
Methylumbelliferone (MUB), purchased from Fluka GmbH (Buchs,
Switzerland), was recrystallized from ethanol three times; 4-MUB-K-
and L-glycosides, used as enzyme substrates, were purchased from
Melford (Su¡olk, UK); bovine serum albumin, Triton X-100, octyl-
glucoside, ethylene glycol from Sigma (St. Louis, MO, USA) and
PIPLC, from Bacillus thuringiensis, from Oxford Glycosystems (Ox-
ford, UK).
2.2. Preparation of erythrocyte membranes (ghosts)
Blood (6^7 ml per donor) was taken from 25 adult volunteer blood
donors, both females and males, aged 25^55 years, from the blood
bank of the Bassini Hospital (Cinisello Balsamo, Milan, Italy). All the
individuals were informed of the purpose of the investigation and
gave their consent. All samples were appropriately screened and
were negative for HIV and hepatitis antibody. Erythrocytes were pre-
pared from heparinized venous blood by the Leucostop 4LT-B ¢lter
(Baxter) standard procedure properly scaled down. Blood samples
were centrifuged for 15 min at 3000Ug, immediately after collection,
plasma and bu¡y coat were aspirated from the surface of the pellet
and discarded. The residual material was diluted (1:1, v/v) with phos-
phate bu¡er saline (PBS) at pH 7.4 and ¢ltered through a Leucostop
4LT-B ¢lter adapted and inserted into a 5 ml syringe. Under micro-
scopic examination the ¢ltrate was completely devoid of leukocytes
and platelets, and consisted of a homogeneous preparation of eryth-
rocytes, which were collected by centrifugation (5 min at 1200Ug) and
washed twice with PBS. Erythrocyte plasma membranes (ghosts) were
prepared by the method of Steck and Kant [25]. Brie£y, washed and
packed erythrocytes were dispersed with 5 mmol/l PBS, pH 8.0 (1:40,
v/v), and lysed by gentle mixing at 4‡C for 20 min. The mixture was
centrifuged (20 min at 105 000Ug) and the pellet, containing the
ghosts, was washed twice with a PBS solution, pH 8.0 (2.5 and 1.25
mmol/l, respectively) and centrifuged as above. Before centrifugation
two thirds of each suspension, obtained from the individual donors,
were pooled and centrifuged. The pellet from this pooled material was
employed throughout the study. Ethylene glycol at a ¢nal concentra-
tion of 30% was added to the remaining portions for storing at 340‡C
in order to preserve glycohydrolase activities for further investiga-
tions.
2.3. Enzyme assays
The studied glycohydrolases (L-GlcNAc-ase, L-GlcA-ase, L-Glc-ase,
L-Gal-ase, K-Glc-ase, K-Gal-ase, K-Man-ase, K-Fuc-ase) were assayed
£uorimetrically [8], using the corresponding 4-MUB-glycoside as sub-
strate. 50 Wl of ghost preparation was incubated in a ¢nal volume of
250 Wl containing 25 Wl of 50 mmol/l citric acid^sodium phosphate
bu¡er (chosen as the most suitable on the basis of preliminary experi-
ments) at the appropriate pH, and 175 Wl of the speci¢c substrate
dissolved in water. The mixtures were incubated in a shaker bath at
37‡C for the established period of time. The reaction was stopped and
£uorescence developed by adding 750 Wl of an alkaline solution
(0.2 mol/l glycine^NaOH bu¡er, containing 0.125 mol/l NaCl, pH
10.75). The control incubation mixtures (blanks) were set up using
incubation mixtures lacking the ghost sample, which was incubated
separately and added immediately before stopping the reaction. Pro-
tein content was determined [26] using bovine serum albumin as
standard. The enzyme activities are expressed as WU/mg protein.
The analytical imprecision of the assay methods for ghost glycohy-
drolases was determined and expressed as the coe⁄cient of variation.
Both intra-run and day-to-day run analyses were performed, using
ghost preparations stored at 340‡ in 30% ethylene glycol.
Sialidase and acetylcholinesterase (AChE), used as reference en-
zymes, were determined as described in [27] and [28], respectively.
2.4. Removal of non-integral, peripheral membrane-associated
glycohydrolases by treatment with high ionic strength solutions
Following the general indications of Clark et al. [29], increasing
amounts of NaCl (up to a ¢nal 1.5 mol/l) were added (¢nal vol-
ume,3.6 ml) to the ghost preparations (10^12 mg protein) homogene-
ously suspended with 3 ml of 1.25 mmol/l PBS at pH 8.0 (equilibrated
at 4‡C). The mixture was gently stirred at 4‡C for 20 min, and cen-
trifuged (10 min at 150 000Ug) at the same temperature. The pellet
was rapidly washed for a given number of times with the above NaCl
containing PBS solution and centrifuged. Both the washings and the
¢nal pellet were analyzed for protein and glycohydrolase content.
2.5. Removal of GPI-anchored glycohydrolases by treatment with
PIPLC
The pellet (containing 2.0^2.5 mg protein), obtained after ghost
treatment with 1.0 mol/l NaCl (that proved to achieve optimal release
of peripherally membrane-associated glycohydrolase activities, see
Section 3) was homogeneously dissolved with 1 ml of acetic acid^
Tris bu¡er (¢nal concentration: 25 mmol/l), pH 7.4, and 200 mU of
PIPLC/mg protein, and incubated at 30‡C in a shaker bath for 60 min
[10]. The mixture was then centrifuged as above and the pellet treated
similarly several times, the supernatants and the ¢nal pellet being
analyzed for protein and glycohydrolase content.
2.6. Solubilization of membrane-bound glycohydrolases by detergent
treatment
The pellet (containing 2.0^2.5 mg protein), obtained after ghost
treatment with 1.0 mol/l NaCl, was homogeneously dissolved with
1 ml PBS solution (equilibrated at 4‡C), after addition of increasing
concentrations of Triton X-100 or octylglucoside (up to 2% or 3%,
respectively) it was gently stirred at 4‡C for 20 min, then centrifuged
at 150 000Ug for 10 min, and the supernatant carefully poured o¡
[30]. This treatment was repeated several more times and the ¢nal
pellet and supernatants analyzed for protein and glycohydrolase con-
tent.
2.7. Statistical analysis
The skewness and kurtosis test [31] showed no signi¢cant di¡erence
from the normal distribution, thus parametric analysis techniques
were used. Estimation of total imprecision by analysis of variance
was performed following the model of Krouwer [32] and NCCLS
recommendations [33].
3. Results
3.1. Assay of glycohydrolases in human erythrocyte ghosts
The experimental conditions found to be optimal for the
assay for human erythrocyte plasma membranes glycohydro-
Table 1





























4.0 150 120 6^65
L-GlcA-ase 4.8 citrate^phosphate 2.00 8.0 90 45 1^90
L-Gal-ase 4.4 citrate^phosphate 0.29 1.6 180 180 20^90
K-Gal-ase 4.3 citrate^phosphate 0.70 4.0 180 180 20^90
K-Fuc-ase 5.0 citrate^phosphate 0.35 0.3 150 150 20^90
K-Glc-ase 5.8 citrate^phosphate 0.33 4.0 120 60 10^100
L-Glc-ase 5.0 citrate^phosphate 0.60 4.0 180 180 20^90
K-Man-ase 5.8 citrate^phosphate 1.00 4.0 180 180 20^90
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lases studied are reported in Table 1. As expected, all tested
enzymes had an acidic pH optimum. With two exceptions, all
the enzymes investigated exhibited a pH^activity curve with a
single maximum; L-GlcNAc-ase had three maxima (pH 3.8,
4.4 and 5.6, the highest of which was that at pH 4.4); K-Glc-
ase displayed a plateau from 5.8 to 8.0. The bu¡er system that
proved to be best for all enzymes was citric acid^sodium
phosphate, and the Km values for the corresponding MUB-
glycoside ranged from a minimum of 0.29U1033 mol/l for L-
Gal-ase to a maximum of 2.00U1033 mol/l for L-GlcA-ase.
The minimum amount of enzyme preparation required (Wg
protein) ranged from 1 Wg for L-GlcA-ase to 20 Wg for
K-Gal-ase, L-Gal-ase, K-Fuc-ase, and L-Glc-ase. The intra-
run coe⁄cient of analytical variation ranged from 1.4% for
L-GlcA-ase to 6.5% for L-Glc-ase, and the day-to-day value
from 2.7% for L-GlcA-ase to 7.3% for K-Glc-ase. The latter
values were established using a ghost preparation dissolved in
1.25 mmol/l PBS containing 30% ethylene glycol and stored at
340‡C. Under these conditions all glycohydrolases main-
tained full activity for at least 7 days. As shown in Fig. 1,
the presence of NaCl, Triton X-100 and octylglucoside may
a¡ect the activity of the glycohydrolases used. NaCl, at
0.2 mol/l concentration, caused a 15^20% activation of
L-GlcNAc-ase, L-Gal-ase, K-Gal-ase and K-Man-ase, with
no e¡ects on the other glycohydrolases. Triton X-100 caused
a concentration-dependent activation, ranging from 20 to
60%, of K-Gal-ase, K-Man-ase, L-Gal-ase, L-GlcNAc-ase
and K-Fuc-ase, and an inhibition up to 50 and 75% of
L-Glc-ase and K-Glc-ase, respectively, with no e¡ect on
L-GlcA-ase. Octylglucoside had a similar, but more pro-
nounced, inhibitory e¡ect on L-Glc-ase and K-Glc-ase, and
an activatory e¡ect (60%) on L-GlcNAc-ase, a moderate in-
hibitory e¡ect on K-Gal-ase, and practically no e¡ect on the
other glycohydrolases. All e¡ects became stable and optimal
around 0.08% concentration for Triton X-100 and 0.35% for
octylglucoside.
3.2. Removal of non-integral, peripheral membrane-associated
glycohydrolases by treatment with high ionic strength
solution
Preliminary experiments showed that the highest release of
glycohydrolases from erythrocyte ghosts by high ionic
strength solutions was obtained with three successive treat-
ments with NaCl, at the optimal ¢nal concentration of 1.0
mol/l. As shown in Table 2, NaCl treatment caused a release
from the ghost preparation of 24% of protein and from a
minimum of 4.1% of K-Glc-ase activity to a maximum of
67.1% of L-Gal-ase activity. A percent release of enzyme ac-
tivity markedly higher than that of total proteins was also
exhibited by L-GlcNAc-ase (42.2%), K-Man-ase (59.1%), and
K-Fuc-ase (47.8%). The release of AChE was only 4% and
that of sialidase null. With reference to the starting ghost
preparation, in the supernatants obtained after treatment,
the speci¢c activity of L-GlcNAc-ase and K-Fuc-ase increased
about two-fold, that of K-Man-ase and L-Gal-ase 2.5-, and
three-fold, whereas that of K-Glc-ase decreased almost six-
fold.
3.3. Removal of GPI-anchored glycohydrolases by treatment
with PIPLC
The proper conditions for release of GPI-anchored proteins
and enzyme activities from the pellet obtained after ghost
treatment with 1.0 mol/l NaCl were set up with preliminary
experiments, using as reference markers sialidase and AChE,
known to be partially bound to the erythrocyte membrane by
a GPI anchor [10,34]. Three successive treatments with
PIPLC, under the conditions described in Section 2, succeeded
in completely releasing PIPLC-sensitive enzymes. Therefore,
the pooled three supernatants were used to determine the
amount of liberated proteins, sialidase and AChE. PIPLC
treatment released 23.7%, 78.4% and 10.2% of bound pro-
teins, sialidase and AChE activity, respectively. These values
are expected on the basis of literature data [10,23,24]. Con-
Fig. 1. E¡ect of the addition of increasing amounts of NaCl (A),
Triton X-100 (B), and octylglucoside (C) on the activity of glycohy-
drolases of human erythrocyte ghosts. The ¢nal concentration of
each added substance is indicated.
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versely, no activity of any of the investigated glycohydrolases
could be detected in the supernatants, indicating that none of
these enzymes was sensitive to PIPLC treatment.
3.4. Solubilization of membrane-bound glycohydrolases by
detergent treatment
Preliminary experiments showed that the conditions provid-
ing maximal glycohydrolase solubilization from the pellet ob-
tained after ghost treatment with 1.0 mol/l NaCl were: (a) a
¢nal concentration of 0.4% (w/v) for Triton X-100 and 1.75%
(w/v) for octylglucoside, and (b) three successive treatments at
the above detergent concentrations. As shown in Table 3,
Triton X-100 and octylglucoside caused the liberation of
about 61% and 69% of pellet-bound proteins, respectively,
with similar degrees of solubilization for K-Glc-ase (89 and
84% with the two detergents, respectively), L-GlcA-ase (61%
and 69%), K-Man-ase (41 and 39%), L-Gal-ase (16 and 20%),
and substantial di¡erences for the other enzymes, especially
L-Glc-ase (73 and 47% for Triton X-100 and octylglucoside,
respectively). The only enzyme that was solubilized with both
detergents to a markedly higher degree than total protein was
K-Glc-ase, whose speci¢c activity was substantially higher in
the supernatants than in the starting pellet. L-Glc-ase was
solubilized to a higher degree than total proteins with Triton
X-100, but not with octylglucoside. L-Gal-ase showed the low-
est degree of solubilization (16 and 20%), thus exhibiting a
markedly higher speci¢c activity in the ¢nal pellet than in the
starting pellet.
Table 3
Solubilization of proteins and membrane-bound glycohydrolases by detergent treatment of the pellet obtained after ghost treatment with 1.0
mol/l NaCl
Enzyme Treatment with Triton X-100 Treatment with octylglucoside


























L-GlcNAc-ase 73.9 35 þ 1.9 69.7 2.8 41 þ 2.5 7 þ 0.4 84.4 40 þ 2.3 57.8 24.7 29.5 þ 1.7 145 þ 8.1
K-Glc-ase 174.9 82.9 þ 7.1 164.1 11.2 96.5 þ 7.3 28 þ 2.2 119.3 56.5 þ 3.7 105.8 12.2 54 þ 3.5 72 þ 4.1
L-GlcA-ase 1076.0 510 þ 15.1 884.0 212.0 520 þ 14.8 530 þ 14.9 1076 510 þ 14.7 989.8 88.4 505 þ 14.5 520 þ 14.9
K-Man-ase 19.6 9.3 þ 0.62 21.3 0.1 12.5 þ 0.74 0.2 þ 0.01 14 6.64 þ 0.41 14.1 0.4 7.2 þ 0.51 2.5 þ 0.17
L-Gal-ase 11.8 5.6 þ 0.42 5.4 6.0 3.2 þ 0.23 15 þ 1.07 7.8 3.7 þ 0.25 4.5 3.1 2.3 þ 0.19 18 þ 1.1
L-Glc-ase 19.2 9.1 þ 0.82 16.8 2.8 9.9 þ 0.87 7 þ 0.62 8.5 4.0 þ 0.5 4.7 3.7 2.4 þ 0.22 22 þ 1.8
K-Fuc-ase 4.6 2.2 þ 0.1 4.3 0.3 2.55 þ 0.11 0.7 þ 0.03 2.6 1.2 þ 0.08 2.2 0.4 1.1 þ 0.07 2.5 þ 0.16
K-Gal-ase 12.1 5.7 þ 0.56 11.8 0.4 6.95 þ 0.63 1.05 þ 0.1 10.1 4.8 þ 0.45 8.6 1.5 4.4 þ 0.42 9 þ 0.86
Starting protein for each detergent treatment: 2.11 mg (corresponding to 74% of the ghost). Two successive treatments with 0.4% (¢nal concen-
tration, w/v) Triton X-100, or 1.75% (¢nal concentration, w/v) octylglucoside were performed followed by centrifugation, according to the pro-
cedure described in Section 2. The two pooled supernatants and ¢nal pellet were analyzed. Solubilized proteins recovered in the supernatants:
1.7 and 1.96 mg with Triton X-100 and octylglucoside, respectively (corresponding to 80.6 and 92.9% of the starting proteins respectively). Pro-
teins in the ¢nal pellet: 0.4 and 0.17 mg with Triton X-100 and octylglucoside, respectively. The data shown are the mean values þ S.D. of ¢ve
replicate determinations. Total activities are expressed in WU, speci¢c activities in WU/mg of proteins. The assay of all glycohydrolases was per-
formed at a ¢nal assay mixture concentration of 0.08% (w/v) Triton X-100 or 0.35% (w/v) octylglucoside.
Table 2
Removal of non-integral, peripheral membrane-associated glycohydrolases by treatment with 1.0 mol/l NaCl
Enzyme NaCl treatment No treatment














L-GlcNAc-ase (pH 4.4) 285 125.4 158.4 33.4 þ 2.0 61.5 þ 3.5 25 þ 1.6 27.6 þ 1.8
K-Glc-ase 2514 102.3 2385.0 294.0 þ 26.2 50.2 þ 4.4 377 þ 31.1 296.0 þ 25.2
L-GlcA-ase 4308 1038.0 3228.0 504.0 þ 15.6 509.0 þ 15.2 510 þ 15.3 502.0 þ 16.3
K-Man-ase 110 64.8 42.0 12.9 þ 0.72 31.7 þ 1.6 6.64 þ 0.4 11.4 þ 0.68
L-Gal-ase 66 44.4 22.2 7.7 þ 0.58 21.7 þ 1.5 3.5 þ 0.3 7.0 þ 0.55
L-Glc-ase 133 19.8 110.7 15.5 þ 1.5 9.7 þ 0.9 17.5 þ 1.6 15.3 þ 1.3
K-Fuc-ase 21 11.4 8.4 2.4 þ 0.11 5.6 þ 0.22 1.35 þ 0.06 2.5 þ 0.12
K-Gal-ase 48 16.5 30.3 5.6 þ 0.5 8.1 þ 0.7 4.77 þ 0.42 4.7 þ 0.4
Sialidase (pH 4.7) 204 n.d. 192.6 23.9 þ 2.10 n.d. 30.45 þ 2.9 24.2 þ 2.12
AChE 66 2.7 61.5 7.7 þ 0.68 1.3 þ 0.11 9.73 þ 0.91 7.6 þ 0.71
Starting ghost preparation: 8.55 mg, as protein. Three successive treatments with 1.0 mol/l NaCl were accomplished, obtaining three superna-
tants (subsequently pooled), and one ¢nal pellet. The protein content of the pooled supernatants was 2.04 mg, corresponding to 23.9% of the
starting protein content. The protein content of the ¢nal pellet was 6.33 mg. Total and speci¢c glycohydrolase activities are expressed as WU
and WU/mg protein respectively. Total and speci¢c acetylcholinesterase activities are expressed as U and U/mg protein respectively. n.d.: not de-
tectable. The data presented are mean values, or mean values þ S.D., of ¢ve replicate determinations using the pooled ghost preparation. The
assay of all glycohydrolases was performed at a ¢nal NaCl concentration of 0.2 mol/l in the assay mixture.
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4. Discussion
The aim of the present investigation was to establish how
several glycohydrolases, namely K- and L-Glc-ase, K- and L-
Gal-ase, L-GlcNAc-ase, L-GlcA-ase, K-Fuc-ase and K-Man-
ase, are associated or bound to the plasma membrane of hu-
man erythrocytes. First, optimal assay conditions were
worked out for all tested enzymes. The data generated con¢rm
previous reports [11] and, thanks to the improved assays, ex-
tend the knowledge on some properties of these enzymes. In
fact, the speci¢c activity values we observed were substantially
higher than those reported previously [23,24], and the coe⁄-
cients of analytical variation (both intra-run and day-to-day
run) were in the range 1.4^7.3% (a performance quite satis-
factory for membrane-bound enzymes). Moreover, we ob-
served that high salt (NaCl) concentrations, and even more,
detergent treatment (Triton X-100, octylglucoside) strongly
a¡ect (either inhibiting or activating) most of the enzymes
investigated. The results obtained (summarized in Fig. 2) re-
garding the mode of membrane association/binding of each
enzyme are consistent with the following pattern: (a) part of
the enzyme can be released by treatment with 1.0 mol/l NaCl,
indicating a membrane association mainly based on a network
of ionic bonds. Presumably, this portion consists of a secreted
form of the enzyme, or blood plasma-derived enzyme, adher-
ing to the erythrocyte surface [29] ; (b) a second part can be
solubilized by treatment with detergents (Triton X-100, octyl-
glucoside) known to di¡erently a¡ect speci¢c membrane mi-
crodomains [13,16^18,30,34]. Therefore, this portion of the
enzyme should belong to the a¡ected microdomain; (c) a third
minor part is constituted by an integral protein pertaining to
membrane domains resistant to either one or the other deter-
gent [13]; (d) none of the investigated enzymes appears to be
sensitive to PIPLC treatment, excluding a membrane anchor-
ing by a GPI bridge or, at least, a PIPLC-sensitive bridge.
Curiously, acidic sialidase (pH 4.7) markedly di¡ers from the
other glycohydrolases in that it is mainly linked via a GPI
anchor, does not exhibit any loose association to the mem-
brane, and is completely resistant to Triton X-100 solubiliza-
tion [6]. Of course, owing to the well-known existence in er-
ythrocytes of a network of molecular connections between
membrane- and cytoskeleton-linked proteins, it cannot be ex-
cluded that the observed pattern of membrane-associated er-
ythrocyte glycohydrolases may be due, at least in part, to a
connection of these enzymes with the cytoskeleton. It should
be emphasized that, although displaying a similar general pat-
tern of mode of association/anchoring to the membrane, dif-
ferences in the distribution of the studied glycohydrolases
among the di¡erent modes of association anchoring are re-
markable. In the case of L-Gal-ase and K-Man-ase the major
part (70% and 61%, respectively) is loosely associated, where-
as for K-Glc-ase the major part is released by detergent treat-
ment (89% and 85% with Triton X-100 and octylglucoside,
respectively), the other glycohydrolases having an intermedi-
ate behavior. These observations are consistent with the no-
tion that glycohydrolases have a di¡erent ‘geographical’ dis-
tribution in the erythrocyte membrane, where some domains
are richer in some enzymes (for instance K-Glc-ase, L-GlcA-
ase, K-Gal-ase in domains more sensitive to the used deter-
gents) and other domains richer in other enzymes, like L-Glc-
ase, which is present mostly in the octylglucoside-resistant
membrane fraction, or like L-Gal-ase, K-Man-ase and K-
Fuc-ase, most of which is associated in a loose way.
Two important questions arise from the presented results:
do the di¡erent modes of membrane anchoring by the indi-
vidual glycohydrolases re£ect post-translational modi¢cations
of a common polypeptide, or the occurrence of isozymes of
di¡erent primary or quaternary structures? What could be
predicted about the di¡erent attachment modes of these en-
zymes from the knowledge of their polypeptide sequence de-
Fig. 2. Percent distribution of protein and di¡erent glycohydrolases of human erythrocyte plasma membrane in: (a) the non-integral, peripheral
membrane-associated portion, released by 1.0 mol/l NaCl treatment (open bar); (b) the integral membrane-bound portion solubilized by Triton
X-100 (hatched top right to bottom left) or octylglucoside (hatched top left to bottom right) treatment; and (c) the integral membrane = bound
fraction resistant to detergent treatment (horizontally hatched, Triton X-100; vertically hatched, octylglucoside). Percent values were calculated
on total protein and enzyme activities recovered in the supernatants and pellets obtained after each treatment assuming an equal distribution of
losses in the di¡erent portions. The experimental data reported in Tables 2 and 3 were used. The ¢gures reported in the columns correspond to
percent values.
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rived from the corresponding cDNAs? To the latter purpose it
should be kept in mind that the tested glycohydrolases are
membrane-bound or associated enzymes, for none of which
the cDNA is known at present. Glycohydrolases with avail-
able cDNA are the lysosomal K-Man-ase [35,36], L-GlcNAc-
ase [37], L-Glc-ase [38,39], K-Fuc-ase [40], K-Gal-ase [41],
K-Glc-ase [42], L-GlcA-ase [43], and the endoplasmic reticu-
lum [44] and Golgi apparatus [45] K-Man-ase. Except for the
brush border glycosidases [46], the only plasma membrane-
bound glycohydrolase having coded cDNA is sialidase [47].
Anyhow, the cDNA of the plasma membrane sialidase is dif-
ferent from that of the lysosomal and cytosolic sialidases
[48,49], and the cDNAs of the lysosomal, endoplasmic retic-
ulum and Golgi apparatus K-Man-ases are also di¡erent, sug-
gesting that the relationship between structural features and
modes of plasma membrane anchoring relationship can be
predicted only relying on the cDNA of the individual plasma
membrane-bound enzymes.
In conclusion, the present investigation, based on the devel-
opment of reliable assays for ghost-bound glycohydrolases,
provides a tentative view of how these enzymes are linked
to the membrane: loose association to the surface, integral
insertion, possible occurrence in di¡erent membrane microdo-
mains. Experiments are presently in progress aiming at (a)
ascertaining the possible involvement of individual isozymes
of each glycohydrolase having a di¡erent mode of membrane
anchoring or association, (b) establishing the presence of gly-
cohydrolases in isolated membrane microdomains, (c) search-
ing for the cDNA of these enzymes in order to study struc-
ture/membrane anchoring relationships and (d) exploring the
behavior of these enzymes in the plasma membrane of eryth-
rocytes during physiological and pathological ageing.
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